Callyspongisines A-D: bromopyrrole alkaloids from an Australian marine sponge, Callyspongia sp.

An extract of the Great Australian Bight marine sponge Callyspongia sp. (CMB-01152) displayed inhibitory activity against the neurodegenerative disease kinase targets casein kinase 1 (CK1), cyclin-dependent kinase 5 (CDK5) and glycogen synthase kinase 3 (GSK3β). Chemical investigation, employing HPLC-DAD-MS single ion extraction protocols, facilitated identification of the new bromopyrrole alkaloids, callyspongisines A-D (1-4), and two known co-metabolites, hymenialdisine (5) and 2-bromoaldisine (6). Structure elucidation of 1-6 was supported by detailed spectroscopic analysis and chemical interconversion, as well as biosynthetic and synthetic considerations. Callyspongisine A (1) is only the second reported example of a natural imino-oxazoline, and the first to feature a spiro heterocyclic framework, while callyspongisines B-D (2-4) were speculated to be storage and handling artefacts of 1. The kinase inhibitory activity detected in Callyspongia sp. (CMB-01152) was attributed to 5.

[1]  J. Kobayashi,et al.  Nagelamides X-Z, dimeric bromopyrrole alkaloids from a marine sponge Agelas sp. , 2013, Organic letters.

[2]  P. Proksch,et al.  From anti-fouling to biofilm inhibition: new cytotoxic secondary metabolites from two Indonesian Agelas sponges. , 2010, Bioorganic & medicinal chemistry.

[3]  L. J. Eldik,et al.  Targeting protein kinases in central nervous system disorders , 2009, Nature Reviews Drug Discovery.

[4]  J. Tepe,et al.  Preparation of hymenialdisine, analogues and their evaluation as kinase inhibitors. , 2009, Current medicinal chemistry.

[5]  G. Terstappen,et al.  Therapeutic targets for Alzheimer's disease , 2009, Expert opinion on therapeutic targets.

[6]  Michael P. Mazanetz,et al.  Untangling tau hyperphosphorylation in drug design for neurodegenerative diseases , 2007, Nature Reviews Drug Discovery.

[7]  I. Chopra,et al.  Anti-staphylococcal activity of indolmycin, a potential topical agent for control of staphylococcal infections. , 2004, The Journal of antimicrobial chemotherapy.

[8]  T. Kaisho,et al.  In Vitro and In Vivo Antibacterial Activities of TAK-083, an Agent for Treatment of Helicobacter pyloriInfection , 2001, Antimicrobial Agents and Chemotherapy.

[9]  Sudarsono,et al.  New alkaloids from the indopacific sponge Stylissa carteri. , 1999, Journal of natural products.

[10]  Kobayashi,et al.  Spongiacidins A-D, new bromopyrrole alkaloids from hymeniacidon sponge , 1998, Journal of natural products.

[11]  L. Szilágyi,et al.  Structural analysis of hydantoins and 2-thiohydantoins in solution using 13C, 1H NMR coupling constants , 1998 .

[12]  D. H. Williams,et al.  Isomers and Tautomers of Hymenialdisine and Debromohymenialdisine , 1996 .

[13]  L. Tillekeratne,et al.  Marine natural products: pyrrololactams from several sponges. , 1985, Journal of natural products.

[14]  L. Mazzarella,et al.  Isolation and X-ray crystal structure of a novel bromo-compound from two marine sponges , 1982 .

[15]  A. Hirota,et al.  Isolation of Indolmycin and Its Derivative as Antagonists of L-Tryptophan , 1978 .

[16]  M. V. Wittenau,et al.  THE STRUCTURE OF INDOLMYCIN , 1961 .